KRRO - NASDAQ

Korro Bio, Inc.

KRRO·NASDAQ

$11.08

+2.1%

HealthcareBiotechnology

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$110.28M

EPS-12.4800

P/E Ratio-0.89

Earnings Date08/11/2026

krro

Total Non-Current Liabilities

Last Annual Value

50.13M

3-Year CAGR

-33%

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Korro Bio, Inc. Competitors Analysis of Total Non-Current Liabilities

KRRO · NASDAQ

Company	Total Non-Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Korro Bio, Inc. NASDAQ:KRRO	50.13M	15.8%	3.1%	N/A
Alto Neuroscience, Inc. NYSE:ANRO	22.22M	-47.4%	-10.9%	N/A
Aura Biosciences, Inc. NASDAQ:AURA	14.13M	-5.7%	108.3%	N/A
Larimar Therapeutics, Inc. NASDAQ:LRMR	2.96M	-14.3%	-11.3%	N/A
Altimmune, Inc. NASDAQ:ALT	40.04M	108.8%	94.1%	56.9%
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	426.00K	-85.9%	N/A	N/A
Quantum-Si incorporated NASDAQ:QSI	2.36M	-46.1%	-30.6%	N/A
RAPT Therapeutics, Inc. NASDAQ:RAPT	2.07M	-22.6%	-4.9%	N/A
Rocket Pharmaceuticals, Inc. NASDAQ:RCKT	23.02M	-3.0%	2.7%	-7.3%
LB Pharmaceuticals Inc Common Stock NASDAQ:LBRX	4.18M	-62.2%	N/A	N/A
Annexon, Inc. NASDAQ:ANNX	23.29M	-7.2%	-6.9%	N/A

Korro Bio, Inc. Fair Value Envelope

KRRO · NASDAQ

Our analysis suggests that KRRO has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $11.08, this represents a potential HIDDEN relative to our calculated worth for Korro Bio, Inc..

HIDDEN

Intrinsic Value

Current Price: $11.08

Related Guides

Blog Categories

Continue your KRRO research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.